Volver a Agenda
New Changes to the National Drug Code in the U.S.
Session Chair(s)
Leyla Rahjou-Esfandiary, PHARMD
Lead CSO, Office of Compliance, CDER
FDA, United States
New Changes to the National Drug Code in the U.S.
¿Tiene una cuenta?
Already a DIA Member? Sign in. Not a member? Join.
Iniciar sesión
Austria Center Vienna
05 feb 2019 7:00 a.m. - 07 feb 2019 5:00 p.m.
Bruno-Kreisky-Platz 1, 1220 Vienna, Austria
Volver a Agenda
Lead CSO, Office of Compliance, CDER
FDA, United States
New Changes to the National Drug Code in the U.S.
¿Tiene una cuenta?